Edward D. Esplin

7.0k total citations · 3 hit papers
118 papers, 2.0k citations indexed

About

Edward D. Esplin is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Edward D. Esplin has authored 118 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Genetics, 31 papers in Pathology and Forensic Medicine and 27 papers in Molecular Biology. Recurrent topics in Edward D. Esplin's work include BRCA gene mutations in cancer (52 papers), Genetic factors in colorectal cancer (29 papers) and Genomics and Rare Diseases (25 papers). Edward D. Esplin is often cited by papers focused on BRCA gene mutations in cancer (52 papers), Genetic factors in colorectal cancer (29 papers) and Genomics and Rare Diseases (25 papers). Edward D. Esplin collaborates with scholars based in United States, Jordan and Israel. Edward D. Esplin's co-authors include Robert L. Nussbaum, Scott T. Michalski, Shan Yang, Glen A. Evans, Adi Gazdar, John D. Minna, Erin O’Leary, Sarah M. Nielsen, M Snyder and Piper Nicolosi and has published in prestigious journals such as Science, JAMA and Circulation.

In The Last Decade

Edward D. Esplin

103 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines

2019 240 citations Scott T. Michalski, Edward D. Esplin et al. profile →
Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer

2022 154 citations Aaron M. Horning, Teri A. Longacre et al. profile →
Germline Genetic Testing After Cancer Diagnosis

2023 66 citations Allison W. Kurian, Rachel Hodan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward D. Esplin United States	22	866	789	539	522	367	118	2.0k
Sung‐Won Kim South Korea	27	924 1.1×	864 1.1×	704 1.3×	791 1.5×	408 1.1×	109	2.3k
Nilsa C. Ramirez United States	20	802 0.9×	469 0.6×	615 1.1×	899 1.7×	324 0.9×	45	2.4k
Catherine A. Schnabel United States	26	1.2k 1.3×	640 0.8×	1.2k 2.3×	1.1k 2.0×	363 1.0×	103	2.8k
Susan J. Ramus United Kingdom	32	1.6k 1.8×	1.3k 1.7×	737 1.4×	690 1.3×	575 1.6×	93	3.2k
Mandy L. Ballinger Australia	25	772 0.9×	398 0.5×	428 0.8×	364 0.7×	158 0.4×	102	1.8k
Dong‐Young Noh South Korea	31	724 0.8×	329 0.4×	928 1.7×	853 1.6×	592 1.6×	77	2.6k
Jonathan D. Marotti United States	21	621 0.7×	570 0.7×	1.1k 2.1×	1.3k 2.6×	376 1.0×	84	2.5k
Daniel Ford United Kingdom	16	616 0.7×	1.2k 1.5×	419 0.8×	445 0.9×	441 1.2×	39	2.2k
Sujit S. Nair United States	27	1.3k 1.5×	473 0.6×	438 0.8×	594 1.1×	119 0.3×	57	2.0k
A.L. Børresen-Dale Norway	20	1.5k 1.7×	339 0.4×	762 1.4×	970 1.9×	352 1.0×	41	2.4k

Countries citing papers authored by Edward D. Esplin

Since Specialization

Citations

This map shows the geographic impact of Edward D. Esplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward D. Esplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward D. Esplin more than expected).

Fields of papers citing papers by Edward D. Esplin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward D. Esplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward D. Esplin. The network helps show where Edward D. Esplin may publish in the future.

Co-authorship network of co-authors of Edward D. Esplin

This figure shows the co-authorship network connecting the top 25 collaborators of Edward D. Esplin. A scholar is included among the top collaborators of Edward D. Esplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward D. Esplin. Edward D. Esplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanayama, Mayuko, Émeline Colomba, Sarah M. Nielsen, et al.. (2025). Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant. Prostate Cancer and Prostatic Diseases.

Roggenbuck, Jennifer, Ana Morales, Christopher Tan, et al.. (2024). Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy. Journal of the Peripheral Nervous System. 29(3). 363–367. 1 indexed citations

Abdel‐Razeq, Hikmat, Abdelghani Tbakhi, Rachel E. Ellsworth, et al.. (2024). Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study. JCO Global Oncology. 10(10). e2400068–e2400068. 1 indexed citations

Young, Sarah, et al.. (2024). Germline gene-specific associations in a large prostate cancer cohort.. Journal of Clinical Oncology. 42(16_suppl). 5102–5102.

Esplin, Edward D., Sarah Young, Emily M. Russell, et al.. (2024). Smoking and pathogenic germline variants in patients with lung cancer.. Journal of Clinical Oncology. 42(16_suppl). 8040–8040.

Nielsen, Sarah M., et al.. (2024). Patterns and Frequency of Pathogenic Germline Variants Among Prostate Cancer Patients Utilizing Multi-Gene Panel Genetic Testing. World Journal of Oncology. 15(5). 801–808.

Wilde, Blake R., Daiki Ueno, Edward D. Esplin, et al.. (2023). FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer. Cancer Discovery. 13(9). 2072–2089. 19 indexed citations

Kunze, Katie L., Michael A. Golafshar, Brandie Heald, et al.. (2023). Germline Genetic Testing in Unselected Squamous and Non‐Squamous Head and Neck Cancers. The Laryngoscope. 133(12). 3378–3388. 3 indexed citations

Morales, Ana, Ren Sheng, Thomas E. Callis, et al.. (2023). Real-World Genetic Testing Utilization Among Patients With Cardiomyopathy. Circulation Genomic and Precision Medicine. 17(1). e004028–e004028. 2 indexed citations

10.

Kanayama, Mayuko, Yidong Chen, Changxue Lu, et al.. (2023). Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer. European Urology Oncology. 7(4). 751–759. 5 indexed citations

11.

Morales, Ana, Kathryn E. Hatchell, Dianalee McKnight, et al.. (2023). Early genetic testing in pediatric epilepsy: Diagnostic and cost implications. Epilepsia Open. 9(1). 439–444. 4 indexed citations

12.

Jain, Yashvardhan, Ellen M. Quardokus, Andreas Bueckle, et al.. (2023). Segmentation of human functional tissue units in support of a Human Reference Atlas. Communications Biology. 6(1). 717–717. 5 indexed citations

13.

Heald, Brandie, Sara Pirzadeh‐Miller, Rachel E. Ellsworth, et al.. (2023). Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives. JNCI Journal of the National Cancer Institute. 116(2). 334–337. 3 indexed citations

14.

Sonpavde, Guru, et al.. (2023). Germline genetic testing of patients with penile carcinoma.. Journal of Clinical Oncology. 41(6_suppl). 10–10. 1 indexed citations

15.

Perez, Kimberly, Heather A. Jacene, Jason L. Hornick, et al.. (2022). SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma. Endocrine Related Cancer. 29(9). 533–544. 9 indexed citations

16.

Hodan, Rachel, Linda Rodgers, Sanjeevani Arora, et al.. (2022). Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer. Journal of Genetic Counseling. 31(4). 949–955. 3 indexed citations

17.

Adib, Elio, Talal El Zarif, Amin H. Nassar, et al.. (2021). CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. British Journal of Cancer. 126(5). 797–803. 18 indexed citations

18.

Bayrak‐Toydemir, Pınar, Lora Jh Bean, Alicia Braxton, et al.. (2018). Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization. Genetics in Medicine. 21(4). 861–866. 14 indexed citations

19.

Chan, Sock Hoai, Weng Khong Lim, Scott T. Michalski, et al.. (2016). Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome. npj Genomic Medicine. 1(1). 16015–16015. 9 indexed citations

20.

Algaze, Claudia, Edward D. Esplin, Alexander Lowenthal, et al.. (2013). Expanding the phenotype of cardiovascular malformations in Adams–Oliver syndrome. American Journal of Medical Genetics Part A. 161(6). 1386–1389. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact